Douleur chronique

Description
Veille informationnelle portant sur la douleur chronique

Sujets couverts
Gestion de la douleur

Sources
PubMed
APA PsycInfo
Embase
CINAHL Complete

Fréquence
Mensuelle

Bibliothécaire responsable
Florian Alatorre
florian.alatorre.chum@ssss.gouv.qc.ca

Catégorie:

Description

Données probantes

  • Laparoscopic adhesiolysis for adhesion-related chronic abdominal and pelvic pain after gynaecological and general surgery: an updated meta-analysis and systematic review
    on 24 mars 2026

    BMC Surg. 2026 Mar 10. doi: 10.1186/s12893-026-03631-7. Online ahead of print.ABSTRACTBACKGROUND: Chronic pain resulting from postoperative adhesions represents a significant clinical concern due to its substantial impact on patient quality of life; however, optimal therapeutic management remains contentious. This systematic review and meta-analysis aimed to evaluate the efficacy of laparoscopic adhesiolysis in alleviating chronic pain attributable to postoperative adhesions, and to assess the influence of adhesion barriers on treatment outcomes.METHODS: A comprehensive systematic review was conducted by searching PubMed, Embase, and Web of Science from database inception through August 2025. Studies reporting pain improvement as the primary outcome, along with safety outcomes (including complication incidence and mortality), were eligible for inclusion. Pooled estimates were calculated using a random-effects model, and heterogeneity was quantified employing the I2 statistic..RESULTS: A total of 30 studies involving 1,450 patients were included in the systematic review. In 27 single-arm observational studies (n = 1,150), laparoscopic adhesiolysis was associated with a pooled pain improvement rate of 67.3% (95% CI 57.5-76.2%), with substantial heterogeneity (I2 = 91%). In contrast, pooled analysis of four randomized controlled trials (n = 271) demonstrated no statistically significant difference in pain improvement between laparoscopic adhesiolysis and diagnostic laparoscopy alone (38.9% vs 36.2%; risk ratio 1.05, 95% CI 0.61-1.83).CONCLUSION: Although observational studies report relatively high rates of pain improvement, these findings should be interpreted as descriptive and hypothesis-generating. The highest level of available evidence from randomized controlled trials does not demonstrate a clinically meaningful benefit of laparoscopic adhesiolysis over diagnostic laparoscopy alone.TRIAL REGISTRATION: PROSPERO CRD42023478049.PMID:41808065 | DOI:10.1186/s12893-026-03631-7

  • Risk Factors for Spinal Cord Stimulator Explant After Implantation for Neuropathic Pain: A Systematic Review
    on 24 mars 2026

    Neuromodulation. 2026 Mar 6:S1094-7159(26)00028-0. doi: 10.1016/j.neurom.2026.02.001. Online ahead of print.ABSTRACTOBJECTIVES: Spinal cord stimulation (SCS) is a safe and effective modality for management of neuropathic pain; however, it can lead to loss of therapy and subsequent device explant in some patients. This systematic review aims to identify risk factors for device explant.MATERIALS AND METHODS: A comprehensive search of the data bases (MEDLINE through PubMed, Embase, Cumulative Index of Nursing and Allied Health Literature [CINAHL], Scopus, Web of Science, and Cochrane Database of Systematic Reviews) was performed from Jan 1, 2003 to Dec 31, 2024. The inclusion criteria were English full-text articles in patients aged ≥18 years with SCS implanted for primary neuropathic condition and subsequently explanted after any period, which studied ≥one risk factor for explant. Two reviewers independently screened articles for inclusion and extracted data. The Newcastle-Ottawa Quality Assessment Scale was used to assess risk of bias. Data on risk factors were categorized and described, with meta-analysis using random effects if amenable.RESULTS: The data base search identified 682 unique studies, of which 21 were included. The risk factors identified for SCS device explant were categorized into device (n = 6 studies: eg, older devices, conventional rechargeable devices, percutaneous electrodes), patient (18 studies: eg, age, sex, mental health, other comorbidities, chronic perioperative opioid use, and preoperative diazepam use), and disease indications (three studies: eg, complex regional pain syndrome, persistent spinal pain syndromes, and chronic pain of surgical origin) and other (eg, two studies: eg, infection). Meta-analysis was not possible owing to heterogeneity in variable definition and analyses among included studies.CONCLUSIONS: This systematic review identified various risk factors for device explant in adult patients receiving SCS for primary neuropathic pain. These factors require further studies to improve patient selection, insertion, and management of SCS devices and chronic pain outcomes.PMID:41793406 | DOI:10.1016/j.neurom.2026.02.001

  • Single Session Behavioral Interventions for Chronic Pain A Systematic Review and Meta Analysis of Randomized Controlled Trials
    on 24 mars 2026

    J Pain. 2026 Mar 13:106220. doi: 10.1016/j.jpain.2026.106220. Online ahead of print.ABSTRACTSingle session interventions (SSIs) for chronic pain are a novel and scalable intervention approach that are far less burdensome than typical 8-session behavioral treatments, and have demonstrated improvements in pain outcomes. Therefore, the current review focuses on systematically summarizing evidence from randomized controlled trials (RCTs) on behavioral SSIs for chronic pain. The review was prospectively registered (PROSPERO CRD42023447224), and the search strategy included seven electronic databases up until 11/2024. Title, abstract, and full text review was conducted with 17 RCTs identified and summarized. Eligible studies were RCTs testing a psychological SSI that targeted pain among adults with chronic pain. Study quality was analyzed using National Institute of Health (NIH)'s Quality Assessment Tool for RCTs. The review focused on synthesizing: 1) the main contents, mode, frequency and duration of interventions for patients with chronic pain; and 2) the effects of SSIs on psychological and physical outcomes. Overall, we found that various SSIs demonstrated efficacy in improving pain outcomes. Specifically, small but significant effects of SSIs were observed for pain intensity (Standardized mean difference [SMD]=0.17) and pain interference (SMD=0.27) compared to control conditions. SSIs also demonstrated significant reductions in pain catastrophizing, anxiety, and depression (SMD = 0.37, 0.29, and 0.25 respectively). Of the 17 RCTs, 13 (76%) had good internal validity, and 4 (24%) had fair internal validity. SSIs can be low burden and improve behavioral pain care access. Finally, we discuss design and methodology recommendations for future research on SSIs for chronic pain. PERSPECTIVE: Findings suggest that SSIs are generally effective in improving pain and other health outcomes across various types of chronic pain conditions. SSIs can be low burden and improve behavioral pain care access, especially in settings where longer-course behavioral treatments are infeasible or not offered.PMID:41833852 | DOI:10.1016/j.jpain.2026.106220

  • Lifestyle and Complementary Approaches to Polycystic Ovary Syndrome During Perimenopause and Menopause A Scoping Review
    on 24 mars 2026

    Am J Lifestyle Med. 2026 Mar 18:15598276261436778. doi: 10.1177/15598276261436778. Online ahead of print.ABSTRACTPolycystic Ovary Syndrome (PCOS) persists across the lifespan, yet management during perimenopause and menopause remains underexplored. This scoping review examined non-pharmacological and non-surgical interventions for adult women with PCOS, with particular attention to lifestyle modifications, complementary approaches, and the influence of chronic pain and mental health on quality of life. Guided by the Arksey and O'Malley five-step framework and Joanna Briggs Institute recommendations, studies published in English from 2000 to 2024 were included. Eligible studies examined adult women with PCOS during perimenopause, menopause, or both, and reported on lifestyle interventions, complementary therapies, chronic pain, or quality-of-life outcomes. Twenty-nine studies met inclusion criteria. Diet and physical activity were the most commonly investigated interventions. More than 15 supplement categories were identified; however, none specifically targeted chronic pain or mental health outcomes. Only two studies addressed chronic pain management, both through dietary supplements. Exercise was the only intervention associated with mental health outcomes. PCOS management during perimenopause and menopause requires a holistic, person-centered approach integrating lifestyle and complementary strategies to address physical, hormonal, chronic pain, and mental health challenges.PMID:41868826 | PMC:PMC12999536 | DOI:10.1177/15598276261436778

  • Ultrasound-Guided Atelocollagen Injection for Chronic Pain After Spinal Surgery: A Retrospective Cohort Study
    on 24 mars 2026

    J Pain Res. 2026 Jan 23;19:549827. doi: 10.2147/JPR.S549827. eCollection 2026.ABSTRACTBACKGROUND: Chronic pain after spinal surgery (CPSS), formerly known as failed back surgery syndrome (FBSS), is a persistent and complex condition that often resists conventional treatments. Recent attention has turned toward paraspinal muscle degeneration as a contributing factor. Injectable type I porcine atelocollagen, known for its anti-adhesive and regenerative properties, has been proposed as a potential intervention, but clinical evidence remains scarce. This study aimed to evaluate the effect of ultrasound-guided atelocollagen injection into paraspinal muscles for patients with CPSS and to identify potential predictors of treatment response.METHODS: This single-center retrospective cohort study was conducted at a tertiary academic institution. 34 adult patients (≥20 years) with a diagnosis of lumbosacral CPSS who received ultrasound-guided purified porcine atelocollagen injections between October 2020 and December 2023 and completed 3-month follow-up without concurrent interventional procedures or medication escalation were included in the analysis. The injection was performed into the paraspinal muscles at the surgical level. The primary outcome was change in pain intensity on the 11-point numeric rating scale (NRS) at 3 months post-treatment. A composite outcome was defined as a ≥1-point reduction in NRS or a Patient Global Impression of Change (PGIC) score of 4 or 5. Exploratory analyses were conducted to identify potential predictive factors.RESULTS: The mean NRS score significantly decreased by 1.62 points (95% CI 0.91-2.33, p<0.001) at 3 months after atelocollagen injection compared to baseline. Neither univariable nor multivariable logistic regression analysis revealed any significant predictive factors for a positive composite outcome. When comparing the responder and non-responder groups based on the composite outcome, the proportion of patients taking anticonvulsants or antidepressants was significantly higher in the non-responder group (54.2% vs 100%, p = 0.028).CONCLUSION: Ultrasound-guided atelocollagen injection into the paraspinal muscles was associated with pain reduction in patients with CPSS. Although the absence of a control group limits causal interpretation, this suggests that atelocollagen injection may have potential as an adjunctive or investigational treatment option for this patient population.PMID:41868300 | PMC:PMC13005222 | […]

  • The Society of Interventional Radiology Practice Guidance Document on Venous Origin Chronic Pelvic Pain in Women
    on 24 mars 2026

    J Vasc Interv Radiol. 2026 Mar 3:107954. doi: 10.1016/j.jvir.2025.107954. Online ahead of print.ABSTRACTThe Women's Health Clinical Specialty Council and Venous Clinical Specialty Council of the Society of Interventional Radiology (SIR) formed a workgroup in collaboration with the SIR Guidelines and Statements Division to create up-to-date society-based consensus recommendations for the diagnosis and treatment of venous origin chronic pelvic pain in women. This practice guidance document serves as a summary of what is required to treat women with this condition, including pre-procedural imaging, treatment options, complication management, and follow-up care.PMID:41786126 | DOI:10.1016/j.jvir.2025.107954

  • ACR Appropriateness Criteria® Postmenopausal Subacute or Chronic Pelvic Pain: Update 2025
    on 24 mars 2026

    J Am Coll Radiol. 2026 Mar 5:S1546-1440(26)00054-2. doi: 10.1016/j.jacr.2026.01.033. Online ahead of print.ABSTRACTChronic pelvic pain, which persists longer than 6 months by definition, is a common condition which affects women of all ages with causes differing by age group. This document will focus on gynecologic origins of chronic pelvic pain, etiologies including chronic pelvic inflammatory disease, postsurgical changes, vaginal or vulvar cysts, and pelvic venous congestion disorder. Ultrasound is the initial imaging modality of choice with MRI or CT of the pelvis may be used in select cases when initial ultrasound is inconclusive. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.PMID:41784596 | DOI:10.1016/j.jacr.2026.01.033

  • ACR Appropriateness Criteria® Joint Pain: Idiopathic Arthritis-Child
    on 24 mars 2026

    J Am Coll Radiol. 2026 Mar 12:S1546-1440(26)00071-2. doi: 10.1016/j.jacr.2026.02.011. Online ahead of print.ABSTRACTThis document details imaging approaches for children with suspected juvenile idiopathic arthritis in the axial and appendicular skeleton. It provides recommendations for the initial radiologic evaluation as well as for follow-up imaging. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.PMID:41817472 | DOI:10.1016/j.jacr.2026.02.011

  • ACR Appropriateness Criteria® Chronic Ankle Pain: Update 2025
    on 24 mars 2026

    J Am Coll Radiol. 2026 Mar 12:S1546-1440(26)00066-9. doi: 10.1016/j.jacr.2026.02.006. Online ahead of print.ABSTRACTChronic ankle pain is common and can be caused by a variety of osseous or soft tissue abnormalities, either alone or in combination. Common etiologies of chronic ankle pain include osteoarthritis, impingement, osteochondral lesion, tarsal coalition, instability, or a chronic sequela of ligament or tendon injury. This document summarizes the current evidence for the appropriate use of specific imaging modalities for each of these clinical scenarios. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.PMID:41817475 | DOI:10.1016/j.jacr.2026.02.006

  • From childhood struggles to adult strains: A systematic review of the impact of adverse childhood experiences on psycho-emotional functioning, pain outcomes, and quality of life in populations experiencing chronic pain
    on 24 mars 2026

    Br J Pain. 2026 Mar 4:20494637261429225. doi: 10.1177/20494637261429225. Online ahead of print.ABSTRACTAdverse childhood experiences (ACEs) are well-documented risk factors for later health problems, such as chronic pain and mental illness. We aimed to synthesise the impact of childhood trauma on psycho-emotional disorders, pain perception and cognitions, and quality of life in individuals with chronic pain. A systematic review was conducted following PRISMA guidelines for systematic reviews and meta-analyses. Eligible studies were identified by searching PubMed, PsychINFO, Embase, and Web of Science, with publication dates from 1988 to April 2023. Inclusion criteria were formulated according to the PECOS framework, and relevant research articles were screened for inclusion. Evidence from 18 studies highlights the significant impact of ACEs (and their typologies) on patients' psycho-emotional well-being, pain outcomes, and overall quality of life, with a cumulative effect emerging. However, significant methodological limitations, such as the lack of standardised measures to classify childhood adversity, prevent us from drawing definitive conclusions about the reported associations. The findings underscore the importance of integrated approaches to pain management that centre on the patient's life history and psycho-emotional status. Future research should address current limitations to strengthen our understanding of the role of ACEs in chronic pain research.PMID:41799412 | PMC:PMC12960269 | DOI:10.1177/20494637261429225

Pratiques innovantes

  • Genetic Determinants of Analgesic Responsiveness: A Focus on CYP2D6 and COMT Polymorphisms in Chronic Pain
    on 13 avril 2026

    Clin J Pain. 2026 Jan 12. doi: 10.1097/AJP.0000000000001358. Online ahead of print.ABSTRACTOBJECTIVES: Interindividual variability in analgesic responsiveness often results in therapy failure (TF) or adverse drug reactions (ADR) and poses a major challenge in chronic pain management, as it is influenced by multiple factors. This exploratory study investigated whether pharmacogenetic (PGx) testing could identify drug-gene-interactions (DGIs) explaining variability in drug response. Additionally, we explored whether genetic predispositions in CYP2D6 and COMT, indicating increased pain sensitivity, are linked to TF.METHODS: We analyzed data from chronic pain patients who underwent pharmacogenotyping due to suspected TF or ADR. PGx panel testing was carried out by a commercial provider. Additional genotyping of COMT rs6269, rs4633, and rs4818 was performed using PCR, RFLP, and Sanger sequencing.RESULTS: PGx panel testing confirmed at least one relevant genetic variant in 45% of the suspected DGIs. Notably, 41% involved the pharmacogenes CYP2D6, CYP2C19, and CYP2C9. Subgroup analyses revealed that patients carrying the COMT high pain sensitivity (HPS) allele, COMT high pain phenotype, or CYP2D6 intermediate metabolizer (IM) phenotype were significantly more likely to experience TF. Logistic regression confirmed both phenotypes as significant predictors of TF.DISCUSSION: Our findings support the relevance of CYP2D6, CYP2C19, and CYP2C9 as key pharmacogenes for PGx testing in chronic pain management. The results suggest that a genetic predisposition in CYP2D6 and COMT, associated with increased pain sensitivity, may contribute to insufficient analgesia and subsequent TF. These insights indicate the potential value of incorporating CYP2D6 and COMT as pain-modulating genetic markers into the broader framework of PGx testing.PMID:41521967 | DOI:10.1097/AJP.0000000000001358

  • Using the Framework for Reporting Adaptations and Modifications to Evidence-Based Implementation Strategies (FRAME-IS) to Document Modifications to a Multilevel Deimplementation Strategy Aimed at Reducing Opioid Prescribing for Chronic Pain
    on 13 avril 2026

    Implement Res Pract. 2026 Jan 5;7:26334895251407338. doi: 10.1177/26334895251407338. eCollection 2026 Jan-Dec.ABSTRACTBACKGROUND: Strategies to implement evidence-based practices often require modifications. A systematic approach to documenting these changes was not widely adopted until the Framework for Reporting Adaptations and Modifications to Evidence-Based Implementation Strategies (FRAME-IS) emerged in 2021, enabling researchers to characterize both proactive and reactive implementation changes. While publications demonstrating the FRAME-IS's application are emerging, few have reflected on the use of the tool itself. The National Institutes of Health-funded Deidentified Opioid Initiative R01 trial, testing strategies to implement the Centers for Disease Control and Prevention guidelines on opioid prescribing, offered a timely chance to assess the FRAME-IS's utility in a multisite, hybrid type-3 trial.METHOD: An interdisciplinary team of researchers, clinicians, and implementers documented modifications using the FRAME-IS across four implementation strategies that comprise an implementation package called systems consultation: (1) audit and feedback, (2) educational meetings, (3) practice facilitation, and (4) prescriber peer consulting. Modifications were needed due to COVID-19, the rise in telemedicine, changes in opioid prescribing, and healthcare system variations.RESULTS: The Deidentified Opioid Initiative was implemented in 32 clinics within two Midwestern healthcare systems using a sequential, multiple-assignment randomized trial. The implementation team completed the FRAME-IS's seven modules for each strategy's modifications and reflected on the process of using the tool, strengths, and limitations.CONCLUSIONS: The team found the FRAME-IS is practical, comprehensive, and user-friendly. It effectively documents modifications and fosters reflection, raising critical questions about implementation. Challenges included role blurring (i.e., researcher/implementer/coordinator), capturing the complexity of cascading modifications (i.e., how one modification leads to another), and a lack of reporting options to capture modifications in a clustered, multisite trial (i.e., clinical staff nested in clinics nested in healthcare systems). Considerations and recommendations from this case study can enhance the FRAME-IS, guide other scholars in its use, and improve the research community's ability to measure the dynamic evolution of implementation […]

  • Best Practices for Dorsal Root Ganglion Stimulation for Chronic Pain: Guidelines from the American Society of Pain and Neuroscience
    on 13 avril 2026

    J Pain Res. 2023 Mar 14;16:839-879. doi: 10.2147/JPR.S364370. eCollection 2023.ABSTRACTWith continued innovations in neuromodulation comes the need for evolving reviews of best practices. Dorsal root ganglion stimulation (DRG-S) has significantly improved the treatment of complex regional pain syndrome (CRPS), and it has broad applicability across a wide range of other conditions. Through funding and organizational leadership by the American Society for Pain and Neuroscience (ASPN), this best practices consensus document has been developed for the selection, implantation, and use of DRG stimulation for the treatment of chronic pain syndromes. This document is composed of a comprehensive narrative literature review that has been performed regarding the role of the DRG in chronic pain and the clinical evidence for DRG-S as a treatment for multiple pain etiologies. Best practice recommendations encompass safety management, implantation techniques, and mitigation of the potential complications reported in the literature. Looking to the future of neuromodulation, DRG-S holds promise as a robust intervention for otherwise intractable pain.PMID:36942306 | PMC:PMC10024474 | DOI:10.2147/JPR.S364370

  • Triage processes at multidisciplinary chronic pain clinics: An international review of current procedures
    on 13 avril 2026

    Can J Pain. 2017 Oct 23;1(1):94-105. doi: 10.1080/24740527.2017.1331115. eCollection 2017.ABSTRACTBackground: Multidisciplinary pain clinics are considered the gold standard for the treatment of chronic pain, yet access to such clinics is difficult and patients' conditions deteriorate while waiting. Instituting a triage process is one way of reducing wait time for some patients and ensuring optimal access given the limited resources available. Surprisingly, there are no established guidelines on how to optimally triage chronic pain patients at tertiary multidisciplinary pain clinics. Aims: The goal of this study was to gather information regarding existing triage systems in multidisciplinary chronic pain clinics worldwide as an initial step toward establishing a definitive evidence-based set of triage guidelines. Methods: A total of 66 multidisciplinary pain clinics worldwide completed an online survey detailing current triage practices at their clinic. The survey was distributed via international and national pain associations. Results: Results showed that the vast majority of multidisciplinary pain clinics (94%) use a triage system, yet many difficulties with these systems have been identified (time requirement, administrative burden, lack of control over scheduling, missing high-priority patients, and prioritizing low-priority patients). The level of satisfaction was noted to be higher in those clinics using a structured triage template. Conclusions: This study identified a need for the elaboration of best practice clinical guidelines for triage processes at tertiary pain clinics. The use of a structured referral template could become a central element to such guidelines.PMID:35005345 | PMC:PMC8735833 | DOI:10.1080/24740527.2017.1331115

  • Latest Evidence-Based Application for Radiofrequency Neurotomy (LEARN): Best Practice Guidelines from the American Society of Pain and Neuroscience (ASPN)
    on 13 avril 2026

    J Pain Res. 2021 Sep 8;14:2807-2831. doi: 10.2147/JPR.S325665. eCollection 2021.ABSTRACTRadiofrequency neurotomy (RFN), also known as radiofrequency ablation (RFA), is a common interventional procedure used to treat pain from an innervated structure. RFN has historically been used to treat chronic facet-joint mediated pain. The use of RFN has more recently expanded beyond facet-joint mediated pain to peripherally innervated targets. In addition, there has also been the emergence of different radiofrequency modalities, including pulsed and cooled RFN. The use of RFN has been particularly important where conservative and/or surgical measures have failed to provide pain relief. With the emergence of this therapeutic option and its novel applications, the American Society of Pain and Neuroscience (ASPN) identified the need for formal evidence-based guidance. The authors formed a multidisciplinary work group tasked to examine the latest evidence-based medicine for the various applications of RFN, including cervical, thoracic, lumbar spine; posterior sacroiliac joint pain; hip and knee joints; and occipital neuralgia. Best practice guidelines, evidence and consensus grading were provided for each anatomical target.PMID:34526815 | PMC:PMC8436449 | DOI:10.2147/JPR.S325665

Pédiatrie

  • Best practices for virtual care to support youth with chronic pain and their families: a rapid systematic review to inform health care and policy during COVID-19 and beyond
    on 13 avril 2026

    Pain Rep. 2021 Jun 3;6(2):e935. doi: 10.1097/PR9.0000000000000935. eCollection 2021 Jul-Aug.ABSTRACTThe COVID-19 pandemic has acutely challenged health systems and catalyzed the need for widescale virtual care and digital solutions across all areas of health, including pediatric chronic pain. The objective of this rapid systematic review was to identify recommendations, guidelines, and/or best practices for using virtual care to support youth with chronic pain and their families (CRD42020184498). MEDLINE, CINAHL, Embase, APA PsychINFO, and Web of Science were searched the week of May 25, 2020, for English language peer-reviewed articles published since 2010 that (1) discussed children and adolescents aged <18 years reporting any type of chronic pain (ie, pain lasting >3 months); (2) focused on any type of virtual care (eg, telephone, telehealth, telemedicine, mHealth, eHealth, online, or digital); and (3) reported on guidelines, best practices, considerations, or recommendations for virtual care. Abstract and full text screening and data extraction were performed in duplicate. Meta-ethnography was used to synthesize concepts across articles. Of 4161 unique records screened, 16 were included addressing diverse virtual care and pediatric chronic pain conditions. Four key themes were identified: (1) opportunities to better leverage virtual care, (2) direct effective implementation of virtual care, (3) selection of virtual care platforms, and (4) gaps in need of further consideration when using virtual care to support youth with chronic pain and their families. No existing guidelines for virtual care for pediatric chronic pain were identified; however, best practices for virtual care were identified and should be used by health professionals, decision makers, and policymakers in implementing virtual care.PMID:34104841 | PMC:PMC8177877 | DOI:10.1097/PR9.0000000000000935

  • Biopsychosocial pain assessment and management in paediatric inflammatory vs non-inflammatory musculoskeletal conditions: a vignette study
    on 24 mars 2026

    Rheumatol Adv Pract. 2026 Jan 19;10(1):rkag007. doi: 10.1093/rap/rkag007. eCollection 2026.ABSTRACTOBJECTIVES: There is no research evidence about how healthcare professionals (HCPs) prioritise assessment and management of pain in different paediatric chronic musculoskeletal conditions (e.g. inflammatory or non-inflammatory). This study investigated and compared paediatric rheumatology HCPs' pain assessment/management priorities in inflammatory and non-inflammatory chronic musculoskeletal conditions and explored perceived barriers to implementation of prioritised pain assessment/management approaches.METHODS: Participants were presented with online vignettes describing a young person with an inflammatory (JIA) or non-inflammatory (diffuse idiopathic pain) chronic musculoskeletal condition. Participants completed closed questions on pain assessment/management priorities and open questions on perceived barriers to implementation of these priorities in clinical practice. Data were analysed using within-subjects bivariate statistical analysis and content analysis.RESULTS: Results from 56 HCPs (11 countries) found that broadly similar pain assessments were selected for both conditions. Biomedical management approaches were more frequently selected for the inflammatory condition, whereas psychosocial approaches were primarily selected for the non-inflammatory condition. Barriers to implementation of assessment/management approaches included limited time, resources, knowledge and skillset and HCPs' habits and beliefs about pain care (e.g. limiting access to components of biopsychosocial pain management due to preconceived beliefs about the musculoskeletal condition).CONCLUSION: Paediatric rheumatology HCPs generally prioritise similar pain assessments for inflammatory and non-inflammatory chronic musculoskeletal conditions. However, some HCPs perceive psychosocial pain management approaches as less important for managing pain in inflammatory conditions. Importantly, pain is always biopsychosocial in nature and clinical guidelines (that emphasise the biopsychosocial perspective) should ideally be followed regardless of condition type.PMID:41769027 | PMC:PMC12937585 | DOI:10.1093/rap/rkag007

  • Building resilience to chronic pain during childhood: The Situate - Experience - Learn - Feel (SELF) Framework
    on 24 mars 2026

    Clin Psychol Rev. 2026 Feb 26;125:102723. doi: 10.1016/j.cpr.2026.102723. Online ahead of print.ABSTRACTChronic pain is a significant global public health problem affecting 1 in 4 adults and 1 in 5 young people. Despite the high prevalence of chronic pain, research into its prevention is scarce. In this review, we draw from current, interdisciplinary evidence to present a conceptual Situate - Experience - Learn - Feel (SELF) Framework that takes a developmental and biopsychosocial-societal approach to building children's resilience against future chronic pain. The SELF Framework considers the impact of one's Situation, including social and societal supports and structures, early life Experiences, Learning of skills and knowledge, and the ability to understand and differentiate Feelings, in establishing SELF-empowerment, SELF-enablement, and SELF-reliance for the management of future pain experiences. We argue that childhood (∼0-10 years) is a developmental period that provides a potentially critical and thus far untapped opportunity to build resilience to chronic pain in adolescence and beyond. Our framework has three pillars: (1) LEARN: 'Building Knowledge and Skills' - targets children's understanding of pain and healthcare and associated behaviours; (2) EXPERIENCE: 'Strengthening Social Support and Building Emotional Resilience' - targets the fostering of social supports, community, positive childhood experiences, and emotional wellbeing; and (3) FEEL: 'Building Brain-Body Integration' - targets the development and maintenance of movement, interoception, and body awareness. For each pillar, we present its definition and scope, an evidence-based rationale, and provide implementation strategies that could reduce the risk of chronic pain in the future. Importantly, the SELF Framework considers that disadvantageous aspects of a child's broader societal/structural and social SITUAT[ION] may demand additional supports to mitigate risk, and we present several avenues for future research on this.PMID:41774945 | DOI:10.1016/j.cpr.2026.102723

  • Adolescent pain reports share genetic overlap with adult chronic pain conditions: A polygenic score analysis using the ABCD study
    on 24 mars 2026

    J Pain. 2026 Mar 12:106260. doi: 10.1016/j.jpain.2026.106260. Online ahead of print.ABSTRACTAdolescent pain complaints may be related to genetic risk for chronic pain across the life course. Identifying whether adolescent pain is genetically linked to chronic pain in adulthood can advance understanding of pain etiology and inform early intervention. Two waves of pain assessments were used from the Adolescent Brain Cognitive Development (ABCD) study, a population-based sample of 11,876 adolescents with 94.0% retention across waves. The analyses included 6,387 adolescents of European-like ancestry (mean ages = 12.03 and 12.93 at waves 2 and 3; 52% males). Two polygenic scores (PGSs) were constructed using genome-wide association study summary statistics from up to 435,917 adults in the UK Biobank. One PGS captured shared genetic risk across 24 pain conditions (General Chronic Pain), while the second captured additional musculoskeletal-specific genetic risk across 11 conditions after adjusting for general pain (Musculoskeletal-specific Pain). Mixed-effects models were used to examine associations between these PGSs and adolescent self-reported pain presence, intensity, recurrence, and multi-site pain. Across both waves, 36.0%-37.0% adolescents reported pain. The General Pain PGS was associated with pain presence (b=0.07, OR=1.07, 95%CI=1.02-1.13, FDR-corrected p=0.023) and intensity (b=0.14, 95%CI=0.07-0.21, FDR-corrected p<0.001); but not recurrent pain (b=0.08, OR=1.08, 95%CI=1.01-1.16, FDR-corrected p=0.091) or multi-site pain (b=0.01, OR=1.00, 95%CI=0.94-1.07, FDR-corrected p=0.958). The Musculoskeletal-specific Pain PGS was not significantly associated with the outcomes. Genetic risk for chronic pain in adulthood, as measured by PGSs, is associated with adolescent pain complaints. Adolescent pain signals early vulnerability for chronic pain, highlighting adolescence for early intervention. PERSPECTIVE: This study links adolescent pain to polygenic risk for adult chronic pain, suggesting that early pain reflects enduring genetic liability and reflects central pain processes. These results provide mechanistic insight into chronic pain across the lifespan and highlight adolescence as a period for intervention.PMID:41831663 | DOI:10.1016/j.jpain.2026.106260